S. Iwata

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

Kazuyoshi Saito, Daisuke Kawabata, Shingo Nakayamada et al. · Annals of the Rheumatic Diseases · 2006 · 345 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis.

Norihito Sato, S. Iwata, Kazuaki Nakamura et al. · The Journal of Immunology · 1995 · 241 citations

Life Sciences, Biochemistry, Cell Biology +16

The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon‐γ and interleukin‐17 production by human CD4+ T cells

Keisuke Maeshima, Kunihiro Yamaoka, Satoshi Kubo et al. · Arthritis & Rheumatism · 2011 · 231 citations

Veterinary Medicine, Immunology, Pharmacotherapy +17

Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.

Tetsuro Sasada, S. Iwata, Norihito Sato et al. · Journal of Clinical Investigation · 1996 · 200 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells

Satoshi Kubo, Kunihiro Yamaoka, Masahiro Kondo et al. · Annals of the Rheumatic Diseases · 2013 · 171 citations

Life Sciences, Immunology, Pharmacology +17